Genetic susceptibility to keloid disease: Transforming growth factor β receptor gene polymorphisms are not associated with keloid disease

Experimental Dermatology

Volumn 13, Issue 2, 2004, Pages 120-124

  Bayat, Ardeshir ^a,b   Bock, O ^c   Mrowietz, U ^c   Ollier, W E R ^a   Ferguson, M W J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BOOTH HALL CHILDREN S HOSPITAL   (United Kingdom)

^c Wythenshawe/Booth Hall Child Hosp ^*  (Germany)

Author keywords

Genetics; Keloid disease scarring; Polymorphisms; Transforming growth factor receptors

Indexed keywords

DNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR III; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; KELOID; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

CASE-CONTROL STUDIES; DNA; DNA PRIMERS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KELOID; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 1342284183     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2004.00165.x     Document Type: Article

References (21)

1. Tuan T L, Nichter L S. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998: 4: 19-24.
2. Russel S B, Trupin K M, Rodriguez-Eaton S, Russel J. Reduced growth factor requirement of keloid-derived fibroblasts may account for tumour growth. Proc Natl Acad Sci USA 1988: 85: 587-591.
3. Marneros A G, Norris J E, Olsen B R, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol 2001: 137: 1429-1434.
4. Bloom D. Heredity of keloids. Review of the literature and report of a family with multiple keloids in five generations. N Y State Med J 1956; 56: 511-519.
5. Omo-Dare P. Genetic studies in keloids. J Natl Med Assoc 1975: 67: 428-432.
6. Datubo-Brown D D. Keloids: A review of the literature. Br J Plast Surg 1990: 43: 70.
7. Massague J. How cells read TGF-β signals. Nat Rev Mol Cell Biol 2000: 1: 169-178.
8. Wrana J L, Attisano L, Weiser R, Ventura F, Massague J. Mechanism of activation of the TGF-β receptor. Nature 1994: 370: 341.
9. Lewis K A, Gray P C, Blount A L et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000: 404: 411.
10. Niessen F B, Spauwen P H, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg 1999: 104: 1435-1458.
11. Peltonen J, Hsiao L L, Jaakkola S et al. Activation of collagen gene expression in keloids: Co-localization of type I and VI collagen and transforming growth factor-β 1 mRNA. J Invest Dermatol 1991: 97: 240-248.
12. Wang X, Smith P, Pu L L, Kim Y J, Ko F, Robson M C. Exogenous transforming growth factor β2 modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 1999: 87: 194-200.
13. Chin G S, Liu W, Peled Z et al. Differential expression of transforming growth factor-β receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 2001: 108: 423-429.
14. Schmid P, Itin P, Cherry G, Bi C, Cox D A. Enhanced expression of transforming growth factor-β type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol 1998: 152: 485-493.
15. Gold L I, Sung J J, Siebert J W, Longaker M T. Type I (RI) and type II (RII) receptors for transforming growth factor-β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound repair. Am J Pathol 1997: 150: 209-222.
16. 1 in human disease. N Engl J Med 2000: 342: 1351-1358.
17. Zhou X, Tan F K, Stivers D N, Arnett F C. Microsatellites and intragenic polymorphisms of transforming growth factor β and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): A preliminary analysis showing no genetic association. Arthritis Rheum 2000: 43: 1068-1073.
18. Wood N A, Thomson S C, Smith R M, Bidwell J L. Identification of human TGF-β1 signal sequence polymorphisms by PCR-RFLP. J Immunol Methods 2000: 234: 117-122.
19. 1) common polymorphisms and plasma levels in keloid disease and hypertrophic scarring. Plast Reconstr Surg 2003: 111 (2): 535-543.
20. 1 polymorphisms and genetic susceptibility in keloid disease and hypertrophic scarring. Br J Plast Surg 2002: 55 (4): 283-286.
21. Conne B, Stutz A, Vassalli J D. The 3′ untraanslated region of messenger mRNA: A molecular hotspot for pathology? Nat Med 2000: 6: 637-641.